건강보험 약가제도 개편 이후 약제 등재 현황 변화

• 영문명: Changes in Drug Listing Trends after the Reform of the Off-patent Pharmaceutical Pricing System in National Health Insurance
• 발행기관: 대한약학회
• 저자명: 이혜재(Hye-Jae Lee)
• 간행물 정보: 『약학회지』제66권 제2호(2022년), 110~113쪽, 전체 4쪽
• 주제분류: 의약학 > 기타의약학
• 파일형태: PDF
• 발행일자: 2022.04.30

영문 초록

In July 2020, the off-patent pharmaceutical price system in Korea was revised from a ‘same ingredient, same price’ principal to a ‘differentiated price’ principal, to accord with requirements met at the time of marketing authorization. This Short Report examined changes in the listing patterns of generic drugs following this policy change using the Pharmaceutical Reimbursement List and Price Table from July 2018 to October 2021. Following the revision, we observed that the number of new products listed on the table had been dropped. The monthly average number of new products was 440 prior to the revision and 84 after the revision. Two case analyses showed that this differentiated pricing system provides less motivation for generic manufactures to participate in the market after first-mover generic products have already been listed. This study reports the latest trends following this policy reform and provides baseline evidence for future policy evaluation.

목차

서론(Introduction)

방법(Methods)

결과 및 고찰(Results and Discussion)

결론(Conclusion)

감사의 말씀(Acknowledgment)

Conflict of Interest

References

키워드

Generic Price Patent Reform Pricing system